Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure

Subhasis Chatterjee, Allan S. Stewart, Lawrence T. Bish, Vasant Jayasankar, Elizabeth M. Kim, Timothy Pirolli, Jeffrey Burdick, Y. Joseph Woo, Timothy J. Gardner, H. Lee Sweeney

Research output: Contribution to journalArticlepeer-review

32 Scopus citations


Background - Apoptosis secondary to acute ischemia and chronic remodeling is implicated as a mediator of heart failure. This study was designed to assess the effect of in vivo viral gene transfer of the anti-apoptotic factor Bcl-2 to block apoptosis and preserve ventricular geometry and function. Methods and Results - In a rabbit model of regional ischemia followed by reperfusion, an experimental group treated with adeno-Bcl-2 was compared with a control group receiving empty vector adeno-null. Function was assessed by echocardiography, and sonomicrometry of the border zone was compared with the normal left ventricle (LV). Animals were killed at 6 weeks, and an additional group was killed after 3 days to see whether virus administration conferred an immediate effect. Animals that were administered Bcl-2 maintained higher ejection fractions at 2, 4, and 6 weeks compared with controls. Sonomicrocrystals demonstrated greater protection of border zone fractional shortening at 6 weeks. The Bcl-2 group had superior preservation of LV geometry with less ventricular dilatation and wall thinning. There was also reduced apoptosis compared with the controls. Finally, in the animals killed at 3 days, no functional difference was observed between the Bcl-2 and control groups. Conclusions - Gene transfer of Bcl-2 preserves LV function after ischemia despite the absence of an observed acute protective effect. The benefit at 6 weeks is postulated to result from a Bcl-2-mediated reduction in apoptosis and ventricular remodeling. Adeno-Bcl-2 administration offers a potential strategy to protect the heart from late postischemic heart failure.

Original languageEnglish (US)
Pages (from-to)I212-I217
Issue number13 SUPPL.
StatePublished - Sep 24 2002


  • Apoptosis
  • Gene therapy
  • Heart failure
  • Myocardial infarction
  • Remodeling

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Viral gene transfer of the antiapoptotic factor Bcl-2 protects against chronic postischemic heart failure'. Together they form a unique fingerprint.

Cite this